XML 71 R57.htm IDEA: XBRL DOCUMENT v3.21.1
Related Parties Transactions (Details)
1 Months Ended 3 Months Ended 12 Months Ended
May 08, 2020
USD ($)
Feb. 03, 2019
May 11, 2018
USD ($)
Jan. 31, 2021
Oct. 31, 2020
USD ($)
May 27, 2019
USD ($)
Mar. 31, 2021
USD ($)
Mar. 31, 2020
USD ($)
Dec. 31, 2020
USD ($)
Dec. 31, 2018
Feb. 07, 2021
USD ($)
Jan. 29, 2021
USD ($)
Jul. 01, 2020
USD ($)
Jan. 21, 2019
USD ($)
Related Parties Transactions (Details) [Line Items]                            
Principal amount                     $ 104,167 $ 132,331   $ 1,000,000
Loan agreement, description                   The advances bear interest rate from 12% to 13.6224% per annum.        
Outstanding advance             $ 2,093   $ 0          
Accrued interest             $ 163,566   166,261          
Aggregate working capital         $ 1,610                  
Advances bear interest, description             0%              
Interest rate percentage       0.00% 6.50%   1.50%              
Loan maturity date         Oct. 30, 2021   Aug. 17, 2020              
Outstanding loan             $ 1,610   1,610          
Outstanding advance balance             312,152   $ 288,445          
Interest expenses             130,229 $ 131,517            
Number of employees                 1          
Accrued employee amounted             72,967   $ 72,704          
Rgene Corporation [Member]                            
Related Parties Transactions (Details) [Line Items]                            
Principal amount             $ 43,266   42,911          
Loan agreement, description             the loan bears interest at 1% per month (or equivalent to 12% per annum) and the maturity date was December 31, 2020.              
Outstanding advance             $ 31,684   31,239          
Accrued interest             $ 12,027   11,227          
BioFirst [Member]                            
Related Parties Transactions (Details) [Line Items]                            
Loan agreement, description             The advances bear interest 1% per month (or equivalent to 12% per annum).              
Loan maturity date             Jun. 30, 2021              
Outstanding advance balance             $ 23,647   23,647          
BioFirst [Member] | Conversion Agreements One [Member]                            
Related Parties Transactions (Details) [Line Items]                            
Stock purchase agreement, description   On May 27, 2019, the Company entered into loan agreements with AsiaGene for NT $100,000, equivalent to $3,510, to meet its working capital needs. Under the terms of the loan agreement, the loan bears interest at 1% per month (or equivalent to 12% per annum) and the loan maturity date was December 31, 2020.                        
Asiangene Corporation [Member]                            
Related Parties Transactions (Details) [Line Items]                            
Outstanding advance             3,560   3,510          
Accrued interest             777   681          
Aggregate working capital           $ 3,510 $ 24,017   0          
Interest rate percentage             0.00%              
Asiangene Corporation [Member] | NT [Member]                            
Related Parties Transactions (Details) [Line Items]                            
Aggregate working capital           $ 100,000                
BioFirst (Australia) [Member]                            
Related Parties Transactions (Details) [Line Items]                            
Principal amount     $ 40,000                   $ 321,487  
Outstanding advance             $ 379,110   373,235          
Advances bear interest, description     The advances bear 0% interest rate and are due on demand prior to June 30, 2020.                      
Interest rate percentage     12.00%       12.00%              
BioLite Taiwan [Member]                            
Related Parties Transactions (Details) [Line Items]                            
Loan agreement, description             The development costs shall be shared 50/50 between BHK and the Company. Under the term of the agreement, BioLite issued relevant development cost to BHK.              
Due from BHK             $ 121,848   123,583          
LBG USA, Inc.[Member]                            
Related Parties Transactions (Details) [Line Items]                            
Outstanding advance             675 675            
BioLite Japan [Member]                            
Related Parties Transactions (Details) [Line Items]                            
Loan agreement, description the Company advanced an amount of $150,000 and the advance bear 0% interest rate.                          
Outstanding advance             150,000   $ 150,000          
Aggregate working capital $ 150,000                          
YuanGene [Member] | Conversion Agreements One [Member]                            
Related Parties Transactions (Details) [Line Items]                            
Aggregate working capital             9,205              
Interest rate percentage                 0.00%          
JIANGS [Member]                            
Related Parties Transactions (Details) [Line Items]                            
Aggregate working capital             $ 18,750   $ 16,627          
Interest rate percentage             0.00%   1.00%          
Interest expenses             $ 5,298 $ 5,269